Carlos Alemán

Prof. Dr. Carlos Alemán

Departament d’Enginyeria Química, EEBE, Universitat Politècnica de Catalunya, C/Eduard Maristany, 10-14, Ed. I2, 08019, Barcelona, Spain
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Corrosion Science
Verified
Journal Article
Closed access
Elaine ArmelinElaine Armelin
Elaine Armelin
RPRosa Pla
Rosa Pla
FLFrancisco Liesa
Francisco Liesa
XRXavier Ramis
Xavier Ramis
IIIñaki Iribarren
Iñaki Iribarren
Carlos AlemánCarlos Alemán
Carlos Alemán

26 September 2016 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
Maria M. Pérez-MadrigalMaria M. Pérez-Madrigal
Maria M. Pérez-Madrigal
MEMiquel G. Edo
Miquel G. Edo
Carlos AlemánCarlos Alemán
Carlos Alemán
In recent years, significant research has aimed at developing environmentally friendly supercapacitors by introducing sustainable natural polymerse. This review summarizes the advances on electrically active cellulose-based devices and the challenges of this exciting field of study.

9 June 2001 in Macromolecules
Verified
Journal Article
Closed access
Carlos AlemánCarlos Alemán
Carlos Alemán
BLB. Lotz
B. Lotz
Jordi PuiggaliJordi Puiggali
Jordi Puiggali

7 March 2008 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KHKendall N Houk
Kendall N Houk
AJArash Jabbari
Arash Jabbari
HHH. K. Hall
H. K. Hall
Carlos AlemánCarlos Alemán
Carlos Alemán

14 October 2010 in Blood
Verified
Journal Article
Open access
PDF file
LALilach Agemy
Lilach Agemy
KSKazuki N. Sugahara
Kazuki N. Sugahara
VKVenkata Ramana Kotamraju
Venkata Ramana Kotamraju
KGKunal Gujraty
Kunal Gujraty
OGOlivier M. Girard
Olivier M. Girard
ERErkki Ruoslahti
Erkki Ruoslahti
The tumor-homing pentapeptide CREKA (Cys-Arg-Glu-Lys-Ala) specifically homes to tumors by binding to fibrin and fibrin-associated clotted plasma proteins in tumor vessels. Previous results show that CREKA-coated superparamagnetic iron oxide particles can cause additional clotting in tumor vessels, which creates more binding sites for the peptide. We have used this self-amplifying homing system to develop theranostic nanoparticles that simultaneously serve as an imaging agent and inhibit tumor growth by obstructing tumor circulation through blood clotting. The CREKA nanoparticles were combined with nanoparticles coated with another tumor-homing peptide, CRKDKC, and nanoparticles with an elongated shape (nanoworms) were used for improved binding efficacy. The efficacy of the CREKA peptide was then increased by replacing some residues with nonproteinogenic counterparts, which increased the stability of the peptide in the circulation. Treatment of mice bearing orthotopic human prostate cancer tumors with the targeted nanoworms caused extensive clotting in tumor vessels, whereas no clotting was observed in the vessels of normal tissues. Optical and magnetic resonance imaging confirmed tumor-specific targeting of the nanoworms, and ultrasound imaging showed reduced blood flow in tumor vessels. Treatment of mice with prostate cancer with multiple doses of the nanoworms induced tumor necrosis and a highly significant reduction in tumor growth.

6 April 2011 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
DADavid Aradilla
David Aradilla
FEFrancesc Estrany
Francesc Estrany
Carlos AlemánCarlos Alemán
Carlos Alemán